Spring 2024
By Colleen Sullivan
The American Gastroenterological Association awarded $300,000 to support a Dana-Farber study into pancreatic ductal adenocarcinoma (PDAC), an aggressive disease that currently has limited and short-lasting treatment options. This funding will enable Jeffrey Patterson-Fortin, MD, PhD, to gain insights into how PDAC responds to immune-based therapies that could provide longer term benefit for patients.